EXACT Therapeutics AS (OSL:EXTX)

Norway · Delayed Price · Currency is NOK

0.8000

+0.1000 (14.29%)

At close: Aug 3, 2026

EXACT Therapeutics AS Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.35	99.54	46.43	69.39	82.91
Short-Term Investments	-	-	-	-	20.78
Cash & Short-Term Investments	24.35	99.54	46.43	69.39	103.69
Cash Growth	-75.54%	114.38%	-33.09%	-33.08%	-35.08%
Other Receivables	36.16	33.67	9.47	8.14	7.61
Total Trade Receivables	36.16	33.67	9.47	8.14	7.61
Total Current Assets	60.51	133.21	55.9	77.53	111.3
Net Property, Plant & Equipment	6.89	4.81	5.42	4.97	6.33
Other Long-Term Assets	-	15.19	-	-	-
Total Assets	67.4	153.2	61.32	82.51	117.63

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	20.72	21.47	14.94	15.63	10.17
Current Portion of Leases	0.43	0.59	0.55	0.5	0.36
Other Current Liabilities	15.54	15.54	-	-	-
Total Current Liabilities	36.69	37.6	15.49	16.13	10.53
Long-Term Leases	-	0.05	0.65	1.19	1.35
Other Long-Term Liabilities	-	-	0.08	0.08	-
Total Long-Term Liabilities	-	0.05	0.73	1.27	1.35
Total Liabilities	36.69	37.65	16.22	17.4	11.89

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.25	0.25	0.13	0.12	0.12
Additional Paid-in Capital	30.32	115.02	44.97	105.13	227.64
Accumulated Other Comprehensive Income	0.14	0.27	-0.04	-	-
Retained Earnings	-	-	-	-40.14	-122.01
Shareholders' Equity	30.71	115.55	45.06	65.11	105.74
Total Liabilities & Equity	67.4	153.2	61.32	82.51	117.63

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.43	0.65	1.2	1.69	1.71
Net Cash (Debt)	23.91	98.89	45.23	67.7	101.97
Net Cash Growth	-75.82%	118.61%	-33.19%	-33.61%	-36.14%
Net Cash Per Share	0.38	2.85	1.41	2.26	3.40
Book Value	30.71	115.55	45.06	65.11	105.74
Book Value Per Share	0.49	3.33	1.40	2.17	3.53
Tangible Book Value	30.71	115.55	45.06	65.11	105.74
Tangible Book Value Per Share	0.49	3.33	1.40	2.17	3.53